NIH Begins Trial to Test Hydroxychloroquine for Treating COVID-19

April 9, 2020

(Reuters) – The National Institutes of Health (NIH) said on Thursday it was testing anti-malaria drug hydroxychloroquine for treating COVID-19, days after several U.S. doctors said they were using the drug on infected patients without evidence that it worked. The use of the decades-old drug, which has been touted by President Donald Trump as a potential weapon against COVID-19, has soared as the United States has quickly become the epicenter of the pandemic.